Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 21/1/2020
SIETES contiene 92882 citas

 1 a 20 de 208 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original
Sampaziotis F, Griffiths WJH. Severe coagulopathy caused by rifampicin in patients with primary sclerosing cholangitis and refractory pruritus. Br J Clin Pharmacol 2012;73:826-7. [Ref.ID 92799]
2.Tiene citas relacionadas
Nardell E, Churchyard G. What is thwarting tuberculosis prevention in high-burden settings?. N Engl J Med 2011;365:79-81. [Ref.ID 90907]
3.Tiene citas relacionadas
Madhi SA, Nachman S, Violari A, Kim S, Cotton MF, Bobat R, Jean-Philippe P, McSherry G, Mitchell C, for the P1041 Study Team. Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children. N Engl J Med 2011;365:21-31. [Ref.ID 90904]
4.Tiene citas relacionadas
Martinson NA, Barnes GL, Moulton LH, Msandiwa R, Hausler H, Ram M, McIntyre JA, Gray GE, Chaisson RE. New regimens to prevent tuberculosis in adults with HIV infection. N Engl J Med 2011;365:11-20. [Ref.ID 90903]
5.Tiene citas relacionadas
Chaisson RE, Chaudhary MA, Conde MB. Moxifloxacin versus ethambutol in initial tuberculosis treatment. Authors' reply. Lancet 2009;373:2198-9. [Ref.ID 86129]
6.Tiene citas relacionadas
Sellier P, Delcey V, Raskine L, Sanson-Le-Pors MJ, Bergmann J-F. Moxifloxacin versus ethambutol in initial tuberculosis treatment. Lancet 2009;373:2198. [Ref.ID 86128]
7.Tiene citas relacionadas
Chang KC, Leung CC. Moxifloxacin versus ethambutol in initial tuberculosis treatment. Lancet 2009;373:2197-8. [Ref.ID 86127]
8.Tiene citas relacionadas Cita con resumen
Conde MB, Efron A, Loredo C, De Souza GRM, Graça NP, Cezar MC, Ram M, Chaudhary MA, Bishai WR, Kritski AL, Chaisson RE. Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial. Lancet 2009;373:1183-9. [Ref.ID 85564]
9.Tiene citas relacionadas Cita con resumen
Rieder HL. Fourth-generation fluoroquinolones in tuberculosis. Lancet 2009;373:1148-9. [Ref.ID 85555]
10.Tiene citas relacionadas
Anónimo. Crunch time for tuberculosis control. Lancet 2009;373:1145. [Ref.ID 85553]
Menzies D, Long R, Trajman A, Dion MJ, Al Jahdali H, Memish Z, Khan K, Gardam M, Hoeppner V, Benedetti A, Schwartzman K. Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis infection. A randomized trial. Ann Intern Med 2008;149:689-97. [Ref.ID 84607]
Lew W, Pai M, Oxlade O, Martin D, Menzies D. Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis. Ann Intern Med 2008;149:123-34. [Ref.ID 83602]
13. Cita con resumen
Perlroth J, Kuo M, Tan J, Bayer AS, Miller LG. Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections. A systematic review of the literature. Arch Intern Med 2008;168:805-19. [Ref.ID 82768]
14.Tiene citas relacionadas
Moet FJ, Pahan D, Oskam L, Richardus JH, for the COLEP Study Group. Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial. BMJ 2008;336:761-4. [Ref.ID 82591]
15.Tiene citas relacionadas
Smith WCS. Chemoprophylaxis in the prevention of leprosy. BMJ 2008;336:730-1. [Ref.ID 82581]
16. Cita con resumen
Raviglione MC, Smith IM. XDR tuberculosis - implications for global public health. N Engl J Med 2007;356:656-9. [Ref.ID 79202]
17. Cita con resumen
Motola D, Vargiu A, Leone R, Cocci A, Salvo F, Ros B, Meneghelli I, Venegoni M, Cutroneo PM, Vaccheri A, Velo G, Montanaro N. Hepatic adverse drug reactions: a case/non-case study in Italy. Eur J Clin Pharmacol 2007;63:73-9. [Ref.ID 79050]
18.Tiene citas relacionadas
Iseman M, Heifets LB. Rapid detection of tuberculosis and drug-resistant tuberculosis. N Engl J Med 2006;355:1606-8. [Ref.ID 78246]
19.Tiene citas relacionadas Cita con resumen
Moore DAJ, Evans CAW, Gilman RH, Caviedes L, Coronel J, Vivar A, Sánchez E, Piñedo Y, Saravia JC, Salazar C, Oberhelman R, Hollm-Delgado M-G, LaChira D, Escombe AR, Friedland JS. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 2006;355:1539-50. [Ref.ID 78242]
20. Cita con resumen
Corbett EL, Marston B, Churchyard GJ, De Cock KM. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet 2006;367:926-37. [Ref.ID 76376]
Seleccionar todas
 1 a 20 de 208 siguiente >>